{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:09:04Z","timestamp":1789168144605,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejogrb.2025.113958","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:23:25Z","timestamp":1744493005000},"page":"113958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Upfront and interval debulking surgery in advanced\/metastatic endometrial cancer in the era of molecular classification"],"prefix":"10.1016","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8015-918X","authenticated-orcid":false,"given":"Fabio","family":"Caiazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Raspagliesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Chiappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ceppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bogani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.113958_b0005","unstructured":"AIOM- AIRTUM- Fondazione AIOM- PASSI- Passi d\u2019Argento- SIAPEC-IAP. I numeri del cancro in Italia 2023. Intermedia Editore, Brescia."},{"issue":"4","key":"10.1016\/j.ejogrb.2025.113958_b0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/healthcare11040571","article-title":"Role of genomic and molecular biology in the modulation of the treatment of endometrial cancer: narrative review and perspectives","volume":"11","author":"Cuccu","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.113958_b0015","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/ijgc-2024-005416","article-title":"Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial","volume":"34","author":"Bogani","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113958_b0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113958_b0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113958_b0030","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2011.05.020","article-title":"Surgical cytoreduction in stage IV endometrioid endometrial carcinoma","volume":"122","author":"Shih","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113958_b0035","doi-asserted-by":"crossref","first-page":"237.e1","DOI":"10.1016\/j.ajog.2021.04.254","article-title":"Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis","volume":"225","author":"Albright","year":"2021","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.ejogrb.2025.113958_b0040","unstructured":"W. H. O. Classification WHO Classification of Tumours Editorial Board, Who Classification of Tumours Editorial. Female Genital Tumours: Who Classification of Tumours. (2020) ISBN: 9789283245049."},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2025.113958_b0045","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/PGP.0000000000000518","article-title":"Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the international society of gynecological pathologists","volume":"38","author":"Soslow","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113958_b0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113958_b0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"Endometrial cancer staging subcommittee, FIGO Women's Cancer Committee. FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.113958_b0060","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113958_b0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.113958_b0070","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00000658-200206000-00007","article-title":"Quality of complication reporting in the surgical literature","volume":"235","author":"Martin","year":"2002","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113958_b0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0300891618784785","article-title":"Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer","volume":"105","author":"Bogani","year":"2019","journal-title":"Tumori"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113958_b0080","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ygyno.2013.08.036","article-title":"Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: a retrospective multi-institutional study of 426 patients in Japan","volume":"131","author":"Eto","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.113958_b0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.28612","article-title":"Association of neoadjuvant chemotherapy with overall survival in women with metastatic endometrial cancer","volume":"3","author":"Tobias","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.113958_b0090","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"European organization for research and treatment of cancer-gynaecological cancer group; NCIC Clinical Trials Group. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"9990","key":"10.1016\/j.ejogrb.2025.113958_b0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.113958_b0100","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","article-title":"Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)","volume":"30","author":"Fagotti","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.113958_b0105","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ijgc-2019-000682","article-title":"TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"29","author":"Reuss","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113958_b0110","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.113958_b0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2022.11.031","article-title":"The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma","volume":"169","author":"Di Dio","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.113958_b0120","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.annonc.2024.02.006","article-title":"Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer","volume":"35","author":"Bogani","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2025.113958_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2022.107125","article-title":"Complete resection after pembrolizumab treatment followed by salvage surgery in stage IVB endometrial cancer: A case report","volume":"94","author":"Taguchi","year":"2022","journal-title":"Int J Surg Case Rep"},{"issue":"21","key":"10.1016\/j.ejogrb.2025.113958_b0130","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer","volume":"390","author":"Chalabi","year":"2024","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.113958_b0135","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"KEYNOTE-522 investigators. Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525002271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525002271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:14:57Z","timestamp":1747653297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525002271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":27,"alternative-id":["S0301211525002271"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.113958","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upfront and interval debulking surgery in advanced\/metastatic endometrial cancer in the era of molecular classification","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.113958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113958"}}